Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06647472 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control

Study acronym: ProMOC
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jun 2026 → Dec 2026
See other at-risk trials from Vejle Hospital

Record History

  1. Primary and study completion pushed from Jun 2026 to Dec 2026v8
  2. Primary and study completion dates: Dec 2025 to Jun 2026v7
  3. Primary and study completion dates: Sep 1, 2025 to Dec 2025v6
  4. Primary and study completion dates: May 1, 2025 to Sep 1, 2025v5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 25 to confirmed 20
    • Primary and study completion dates: Feb 1, 2025 to May 1, 2025
    • Site details revised
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 21, 2024 to Nov 15, 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Vejle Hospital
29 trials monitored
See 2 trials at risk
The key objective of the study is to gain an understanding of the biochemical processes that contribute to orthokeratology lenses being more effective in specific individuals compared to others. With this knowledge, we hope to optimize treatment effectiveness in those currently experiencing less favorable outcomes from treatment in the future. The primary aim is to investigate differences in protein levels in children using orthokeratology lenses with various effects of myopia control. Hypothesis: There is a significant difference in the expression of molecules in children with various effects of myopia control.
Trial Details
NCT Number NCT06647472
Lead Sponsor Vejle Hospital
Collaborators: University of Aarhus
Conditions
(from sponsor)		 Myopia, Healthy, Orthokeratology
Related terms Myopia
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov